Mission Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Buy |
1,856
+6
| +0.3% | +$754 | 0.01% | 598 |
|
|
2025
Q1 | $253K | Sell |
1,850
-471
| -20% | -$64.5K | 0.01% | 558 |
|
|
2024
Q4 | $355K | Buy |
2,321
+254
| +12% | +$38.8K | 0.01% | 495 |
|
|
2024
Q3 | $401K | Buy |
2,067
+154
| +8% | +$29.9K | 0.01% | 457 |
|
|
2024
Q2 | $443K | Buy |
1,913
+87
| +5% | +$20.2K | 0.01% | 417 |
|
|
2024
Q1 | $394K | Buy |
1,826
+66
| +4% | +$14.2K | 0.01% | 460 |
|
|
2023
Q4 | $455K | Sell |
1,760
-16
| -0.9% | -$4.14K | 0.01% | 374 |
|
|
2023
Q3 | $456K | Buy |
1,776
+184
| +12% | +$47.3K | 0.02% | 344 |
|
|
2023
Q2 | $453K | Sell |
1,592
-3
| -0.2% | -$854 | 0.02% | 347 |
|
|
2023
Q1 | $443K | Buy |
1,595
+26
| +2% | +$7.23K | 0.02% | 348 |
|
|
2022
Q4 | $434K | Buy |
1,569
+64
| +4% | +$17.7K | 0.02% | 334 |
|
|
2022
Q3 | $402K | Sell |
1,505
-38
| -2% | -$10.2K | 0.02% | 322 |
|
|
2022
Q2 | $315K | Sell |
1,543
-97
| -6% | -$19.8K | 0.02% | 373 |
|
|
2022
Q1 | $345K | Sell |
1,640
-156
| -9% | -$32.8K | 0.02% | 367 |
|
|
2021
Q4 | $431K | Buy |
+1,796
| New | +$431K | 0.02% | 332 |
|